| Registration |
|
| from 09.00 |
Main Foyer |
| |
|
|
|
|
| Pfizer Ltd Satellite Session |
| 11.00-12.00 |
Main Auditorium |
|
|
Critical issues in adolescent
endocrinology: from genetics to transitional care |
|
|
|
|
|
|
| LUNCH |
|
| 12.00-12.30 |
Hall D |
| |
|
|
|
|
| Society for Endocrinology Dale Medal Lecture |
| 12.30-13.15 |
Main Auditorium Chair: Bloom SR
(London) |
| S1 |
12.30 |
A genetic analysis of insulin and
diabetes regulated gene expression
Kahn CR (Boston, USA) |
|
|
|
|
|
|
| Symposium 1: Endocrine complications of
systemic disorders |
| 13.15-14.45 |
Queen's Suite 1 Chair: Wass JAH
(Oxford) |
| S6 |
13.15 |
The metabolic effects of antiretroviral
therapy
Danner S (Amsterdam, The Netherlands) |
|
|
|
| S7 |
13.45 |
Parathyroid hormone in children with
chronic renal failure
Rees L (London) |
|
|
|
| S8 |
14.15 |
The endocrinology of critical care
Cooper MS (Birmingham) |
|
|
|
|
|
|
| Symposium 2: The endocrinology of the kidney |
| 13.15-14.45 |
Queen's Suite 2 Chair: Pearce S
(Newcastle) |
| S9 |
13.15 |
Lessons from the genetic hypercalciuric
stone forming rat
Bushinsky DA (New York, USA) |
|
|
|
| S10 |
13.45 |
Regulating PTH responses in the kidney
Friedman PA (Pittsburgh, USA) |
|
|
|
| S11 |
14.15 |
The WNK kinases: novel regulations of
sodium and potassium transport in the kidney
O’Shaughnessy K (Cambridge) |
|
|
|
|
|
|
| Clinical Management Workshop 1: Diagnosis and
management of steroid deficiency |
| 13.15-14.45 |
Main Auditorium Chair: Howlett T
(Leicester) |
| S38 |
13.15 |
Why is the management of corticosteroid
deficiency still controversial?
Lightman SL (Bristol) |
|
|
|
| S39 |
13.45 |
Diagnosing the suppressed adrenal
Stewart PM (Birmingham) |
|
|
|
| S40 |
14.15 |
Glucocorticoid resistance
Lamberts S (Rotterdam, The Netherlands) |
|
|
|
|
|
|
| TEA |
|
|
| 14.45-15.15 |
Hall D |
| |
|
| Symposium 3: Thyroid disease in pregnancy and
childhood |
| 15.15-17.30 |
Main Auditorium Chair:
Lazarus J (Cardiff) |
| S12 |
15.15 |
Maternal thyroid dysfunction
Weetman A (Sheffield) |
|
|
|
| S13 |
15.45 |
Maternal and placental
control of thyroid hormone availability for the foetus
Köhrle J (Berlin, Germany) |
|
|
|
| S14 |
16.15 |
Neuropsychological
consequences of thyroid hormone deficiency
Rovet J (Toronto, Canada) |
|
|
|
| S15 |
16.45 |
Diagnosis and management of
thyroid dysfunction in childhood
Grüters-Kieslich A (Berlin, Germany) |
|
|
|
| Oral Communications 1: Diabetes and metabolism |
| 15.15-17.30 |
Queen's Suite 1 Chairs:
Bloom SR (London) & White A (Manchester) |
| OC1 |
15.15 |
Plasticity in myogenesis and skeletal muscle metabolism via insulin and
IGF receptor-mediated Akt activation
Gonzalez I, Cosgrove RA, & Pell JM |
|
|
|
| OC2 |
15.30 |
The relationship of beta-cell function with age: effect of population
migration
Heald AH, Anderson SG, Patel J, Rudenski A, Vyas A, Laing I, Hughes
E, Prabharakan D, Durrington P & Gibson JM |
|
|
|
| OC3 |
15.45 |
Depot specific glucocorticoid regulation of key components of the insulin
signalling cascade in human adipose tissue
Gathercole LL, Bujalska IJ, Stewart PM & Tomlinson JW |
|
|
|
| OC4 |
16.00 |
Effect of cholesterol depletion on IGF-induced cell survival: the role
of caveolar and non-caveolar domains
Matthews LC, Taggart MJ & Westwood M |
|
|
|
| OC5 |
16.15 |
Changes in gut hormones after Roux-en-Y gastric bypass for morbid obesity
favour an anorectic state
Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG & Aylwin
SJB |
|
|
|
| OC6 |
16.30 |
Analysis of post-translational processing and trafficking of agouti-related
protein
Pritchard LE, Creemers JWM, Gyte A, Davies N, Le Rouzic P, Lawrence
C, Luckman S, Brennand JC & White A |
|
|
|
| OC7 |
16.45 |
Calcitonin gene-related peptide (CGRP) II mRNA in human subcutaneous
adipose tissue is altered by menopausal status
Gupta P, Harte AL, Hill MJ, Barnett AH, Sturdee DW, Kumar S & McTernan
PG |
|
|
|
| OC8 |
17.00 |
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist
BIIE0246 attenuates the effect of endogenous and exogenous peptide YY (3-36) on
food intake
Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA & Bloom
SR |
|
|
|
| OC9 |
17.15 |
Testosterone improves functional capacity and symptoms in men with chronic
heart failure: a double-blind placebo-controlled trial
Malkin CJ, Pugh PJ, Jones RD, van Beek E, West JN, Channer KS & Jones
TH |
|
|
|
|
|
|
| Oral Communications 2: Reproduction and
growth |
| 15.15-17.30 |
Queen's Suite 2 Chairs: Franks SJ (London)
and Mason H (London) |
| OC10 |
15.15 |
Glucocorticoid-induced apoptosis in human decidua: a novel role for 11
beta-hydroxysteroid dehydrogenase in late gestation
Chan JCY, Evans KN, Innes B, Bulmer JN, Stewart PM, Hewison M & Kilby
MD |
|
|
|
| OC11 |
15.30 |
A defect in the DHEA-DHEAS shuttle defines a novel cause of polycystic
ovary syndrome
Arlt W, Hammer F, Filko D, Chalder SM, Hughes BA, Sanning P, Schofl
C & Stewart PM |
|
|
|
| OC12 |
15.45 |
Direct inflammatory action of triiodothyronine on human ovarian surface
epithelial cells in vitro
Rae MT, Gubbay O, Kostogiannou A, Niven D, Critchley HOD & Hillier
SG |
|
|
|
| OC13 |
16.00 |
A novel autocrine/paracrine inside-out signalling pathway that cross-talks
the prostanoid and GnRH receptors in pituitary cells
Naor Z, Naidich M, Pawson AJ, Morgan K, Battersby S, MacPherson
S, Millar M, Jabbour HN & Millar RP |
|
|
|
| OC14 |
16.15 |
Pathophysiology and genetics of congenital adrenal hyperplasia caused
by P450 oxidoreductase deficiency
Dhir V, Ivison HE, Walker EA, Draper ND, Hammer F, Malunowicz EM,
Stewart PM, Shackleton CHL & Arlt W |
|
|
|
| OC15 |
16.30 |
Early preantral follicle development in polycystic ovaries (PCO) differs
according to ovulatory status
Franks S, Stubbs S, Webber LJ & Hardy K |
|
|
|
| OC16 |
16.45 |
A densitometric and architectural analysis of the skeleton in adults
with varying degrees of GH deficiency
Murray RD, Adams JE & Shalet SM |
|
|
|
| OC17 |
17.00 |
Disruption of intramembranous and endochondral bone development in TRalpha
2 null mice
Bassett JHD, O'Shea PJ, Nordstrom K, Vennstrom B & Williams
GR |
|
|
|
|
|
|
| Clinical Endocrinology Trust Visiting
Professor Lecture |
| 17.30-18.15 |
Main Auditorium Chair: Rees L (London) |
| S2 |
17.30 |
Growth hormone - not only for growth, but for life?
Christiansen JS (Aarhus, Denmark) |
|
|
|
|
|
|
| Welcome Reception |
| 18.30-19.15 |
Hall D |
| |
|
|
|
|
| Buffet and Boogie |
| 19.30-late |
Bar Med (ticket only) |